{
    "clinical_study": {
        "@rank": "90953", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the safety of lofexidine in the treatment of\n      opiate withdrawal.  Preliminary data will also be obtained to assess the ability of\n      lofexidine to alleviate opiate withdrawal signs and symptoms."
        }, 
        "brief_title": "Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3", 
        "condition": [
            "Opioid-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Opioid-Related Disorders", 
                "Substance Withdrawal Syndrome", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "59 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000354", 
            "org_study_id": "NIDA-3-0012-3", 
            "secondary_id": "Y01-3-0012-3"
        }, 
        "intervention": {
            "intervention_name": "Lofexidine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Lofexidine", 
                "Analgesics, Opioid"
            ]
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19104 6178"
                }, 
                "name": "University of Pennsylvania"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Safety Evaluation of Lofexidine for Treatment of Opioid Withdrawal", 
        "overall_official": {
            "affiliation": "PDVAMC Treatment Research Center", 
            "last_name": "Charles O'Brien, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000354"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Pennsylvania", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "July 1996", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 1996"
    }, 
    "geocoordinates": {
        "University of Pennsylvania": "39.952 -75.164"
    }
}